BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34239754)

  • 1. A Case of Effective Mepolizumab Induction Therapy for Severe Eosinophilic Granulomatosis with Polyangiitis Diagnosed by Eosinophilic Cholecystitis and Interstitial Nephritis.
    Hattori K; Teramachi Y; Kobayashi Y; Ito T; Morinaga T; Tamai H; Yamamoto Y
    Case Rep Rheumatol; 2021; 2021():6678893. PubMed ID: 34239754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.
    Hayama Y; Tomyo F; Ueno M; Asakawa S; Arai S; Yamazaki O; Tamura Y; Mochizuki M; Ohashi R; Shibata S; Fujigaki Y
    Intern Med; 2021 Dec; 60(23):3759-3764. PubMed ID: 34092738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab.
    Kai Y; Yoshikawa M; Matsuda M; Suzuki K; Ohara H; Iguchi N; Kasamatsu T; Uno K; Fujioka N; Fujita Y; Muro S
    Allergy Asthma Clin Immunol; 2022 Feb; 18(1):14. PubMed ID: 35183225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis.
    Ito H; Mishima Y; Cho T; Ogiwara N; Shinma Y; Yokota M; Anzai K; Tsuda S; Nagata J; Kojima S; Sasaki N; Wakabayashi T; Watanabe N; Suzuki T
    Case Rep Gastroenterol; 2020; 14(3):668-674. PubMed ID: 33442347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Eosinophilic Granulomatosis With Polyangiitis: A Case of Refractory Peripheral Neuropathy and Comorbid Chronic Progressive Pulmonary Aspergillosis Treated With Mepolizumab.
    Sekiya R; Soma T; Nakagome K; Nagata M
    Cureus; 2024 Jan; 16(1):e52192. PubMed ID: 38222984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mepolizumab administration for eosinophilic granulomatosis with polyangiitis in an elderly patient with an abrupt onset of limb ischaemia and peripheral neuropathy: A case-based literature review.
    Terashima S; Yamaguchi M; Ishihara T; Hagita J; Katsuno T; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Ishimoto T; Banno S; Ito Y
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):142-147. PubMed ID: 36107735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy.
    Faverio P; Bonaiti G; Bini F; Vaghi A; Pesci A
    Ther Clin Risk Manag; 2018; 14():2385-2396. PubMed ID: 30573961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
    Nishihara M; Hamaguchi M; Ikumi N; Nishiwaki A; Sugiyama K; Nagasawa Y; Tsuzuki H; Yoshizawa S; Tanikawa Y; Asatani S; Kobayashi H; Takei M; Kitamura N
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):354-359. PubMed ID: 33970058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent atelectasis and brain infarction in a patient with anti-neutrophil antibody negative eosinophilic granulomatosis with polyangiitis: a case report.
    Sada KE; Miyauchi A; Hashimoto D; Ino R; Nojima S; Yamanaka S; Kawamura M
    BMC Rheumatol; 2021 Sep; 5(1):28. PubMed ID: 34465397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerulonephritis and Interstitial Nephritis Originating from Vasculitis of the Interlobular Arteries of the Kidney in a Patient with Eosinophilic Granulomatosis with Polyangiitis.
    Nawata T; Shibuya M; Takeshita Y; Kubo M; Uesugi N; Yano M
    Case Rep Rheumatol; 2022; 2022():9606981. PubMed ID: 36212163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Nara M; Saito M; Abe F; Komatsuda A; Wakui H; Takahashi N
    Intern Med; 2019 Dec; 58(24):3583-3587. PubMed ID: 31391393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Tsurikisawa N; Oshikata C; Watanabe M; Fukuda N; Yamaguchi T; Kiyohara H; Kaneko T
    Int Arch Allergy Immunol; 2021; 182(8):744-756. PubMed ID: 33887721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic granulomatosis with polyangiitis presenting with eosinophilic myocarditis as the only organ involvement.
    Itagaki T; Miura T; Karasawa S; Nomoto F; Takamatsu T; Sunohara D; Komatsu T; Tanaka K; Mochidome T; Kasai T; Ikeda U
    J Cardiol Cases; 2023 Apr; 27(4):172-175. PubMed ID: 37012922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on eosinophilic granulomatosis with polyangiitis.
    Furuta S; Iwamoto T; Nakajima H
    Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement.
    Afiari A; Gabriel A; Gaiki MR
    Cureus; 2020 Jul; 12(7):e9242. PubMed ID: 32821588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic granulomatous with polyangiitis complicated by swelling of the oral cavity floor and cervical soft tissue as initial manifestation mimicking IgG4-related disease: A case report.
    Suzuki T; Moriyama M; Takano I; Miyajima N; Yoshioka Y; Honda M; Kondo M; Shokei S; Araki A; Kadota K; Ichinose K
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):178-181. PubMed ID: 37902453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic Granulomatosis with Polyangiitis Manifested by Cholecystitis and Mononeuritis Multiplex: A Case Report.
    Mobini M; Cheraghmakani H; Torabizadeh Z; Emadian O; Nezhadi Kelarijani F
    Iran J Med Sci; 2018 May; 43(3):332-335. PubMed ID: 29892153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis.
    Pradhan RR; Nepal G; Mandal S
    Pulm Med; 2019; 2019():4376380. PubMed ID: 30941214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.
    Vultaggio A; Nencini F; Bormioli S; Vivarelli E; Dies L; Rossi O; Parronchi P; Maggi E; Matucci A
    Allergy Asthma Immunol Res; 2020 Sep; 12(5):885-893. PubMed ID: 32638567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory diffuse alveolar hemorrhage caused by eosinophilic granulomatosis with polyangiitis in the absence of elevated biomarkers treated successfully by rituximab and mepolizumab: A case report.
    Shiroshita A; Nakashima K; Motojima S; Aoshima M
    Respir Med Case Rep; 2019; 26():112-114. PubMed ID: 30603598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.